Imunon lets three top executives take part of salary in stock through September

Imunon, Inc. disclosed in an 8-K dated August 11, 2026 that its Compensation Committee and Board of Directors approved arrangements letting certain executive officers choose to take a portion of their base salary as common stock, with those officers also receiving extra shares tied to that election.¹

Under the program, President and CEO Stacy Lindborg may elect to receive up to 50% of her base salary in shares. She is set to receive additional shares equal to 12% of the net stock payment, a figure amended to 35% for shares issued on August 14 and then to 17.5% for each pay date from August 28 through September 25, 2026.¹

Executive Chairman Michael Tardugno can take up to 100% of his base salary in stock. His additional share allotment is set at 20% for the July 31 payment, 40% for the August 14 payment, and 20% for each pay date running from August 28 to September 25, 2026.¹

Chief Medical Officer Douglas Faller may elect up to 40% of his salary in shares. His additional shares start at 12% of the net stock payment, amended to 15% for each pay date from July 31 through September 25, 2026.¹

On the securities exemptions, the filing states that the shares issuable to Lindborg and Tardugno are treated as exempt from registration under Section 4(a)(2) of the Securities Act of 1933, covering transactions that do not involve a public offering.¹ Separately, Faller's shares will be issued under the Imunon, Inc. 2018 Stock Incentive Plan, as amended and restated.¹

The filing was signed by General Counsel and Corporate Secretary Susan Eylward on behalf of the company.